Answers are grounded in this paper and cite their sources.
Introduction: Oral lichen planus is a chronic inflammatory disorder affecting the oral cavity. Some patients are refractory to standard treatment lines or experience adverse effects, requiring other lines of treatment. We conducted a literature review to assess the efficacy and safety of hydroxychloroquine in medical treatment of oral lichen planus. Material and methods: We searched several databases and included RCTs and non-RCTs, case series and case reports, addressing the use of hydroxychloroquine. Results: 13 studies were included, giving a total of 439 participants with oral lichen planus, 351 receiving hydroxychloroquine. All studies highlighted a clinical and/or symptomatic improvement after initiating treatment with hydroxychloroquine. This improvement was statistically significant in seven studies. Two authors reported cases of recurrence during follow-up duration. Side-effects have been reported in nine studies. They concerned digestive system, nervous system, dermatology, ophtalmology, psychiatry, ORL/stomatology and abnormality of laboratory examinations. Conclusion: hydroxychloroquine is a treatment alternative for oral lichen planus, especially in recalcitrant forms. However, additional studies are needed to provide sufficient levels of evidence to justify the therapeutic rationale for this prescription.
No takes yet. Share an insight, caveat, or question.
Thomasson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: